Skip to main content
Top
Published in: BMC Public Health 1/2008

Open Access 01-12-2008 | Research article

The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types

Authors: AS Abdulamir, RR Hafidh, N Abdulmuhaimen, F Abubakar, KA Abbas

Published in: BMC Public Health | Issue 1/2008

Login to get access

Abstract

Background

Nasopharyngeal carcinoma (NPC) and other head and neck cancer (HNCA) types show a great epidemiological variation in different regions of the world. NPC has multifactorial etiology and many interacting risk factors are involved in NPC development mainly Epstein Barr virus (EBV). There is a need to scrutinize the complicated network of risk factors affecting NPC and how far they are different from that of other HNCA types.

Methods

122 HNCA patients and 100 control subjects were studied in the region of the Middle East. Three types of HNCA were involved in our study, NPC, carcinoma of larynx (CL), and hypopharyngeal carcinoma (HPC). The risk factors studied were the level of EBV serum IgG and IgA antibodies measured by ELISA, age, sex, smoking, alcohol intake, histology, and family history of the disease.

Results

EBV serum level of IgG and IgA antibodies was higher in NPC than CL, HPC, and control groups (p < 0.01). NPC was associated with lymphoepithelioma (LE) tumors, males, regular alcohol intake, and regular smoking while CL and HPC were not (p < 0.05). CL and HPC were associated with SCC tumors (p < 0.05). Furthermore, NPC, unlike CL and HPC groups, was not affected by the positive family history of HNCA (p > 0.05). The serum levels of EBV IgG and IgA antibodies were higher in LE tumors, regular smokers, younger patients, and negative family history groups of NPC patients than SCC tumors, non-regular smokers, older patients and positive family history groups respectively (p < 0.05) while this was not found in the regular alcoholics (p > 0.05).

Conclusion

It was concluded that risk factors of NPC deviate much from that of other HNCA. EBV, smoking, alcohol intake, LE tumors, male patient, and age > 54 years were hot risk factors of NPC while SCC and positive family history of the disease were not. Earlier incidence, smoking, LE tumors, and negative family history of the disease in NPC patients were associated much clearly with EBV. It is proposed that determining the correct risk factors of NPC is vital in assigning the correct risk groups of NPC which helps the early detection and screening of NPC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Erkal HS, Serin M, Cakmak A: Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol. 2001, 61 (3): 247-56. 10.1016/S0167-8140(01)00448-0.CrossRefPubMed Erkal HS, Serin M, Cakmak A: Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol. 2001, 61 (3): 247-56. 10.1016/S0167-8140(01)00448-0.CrossRefPubMed
2.
go back to reference Cooper JS, Lee H, Torrey M, Hochster H: Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience. Int J Radiat Oncol Biol Phys. 2000, 47 (4): 861-6.CrossRefPubMed Cooper JS, Lee H, Torrey M, Hochster H: Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience. Int J Radiat Oncol Biol Phys. 2000, 47 (4): 861-6.CrossRefPubMed
3.
go back to reference Burt RD, Vaughan TL, McKnight B: Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Int J Cancer. 1992, 52 (4): 549-56. 10.1002/ijc.2910520409.CrossRefPubMed Burt RD, Vaughan TL, McKnight B: Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Int J Cancer. 1992, 52 (4): 549-56. 10.1002/ijc.2910520409.CrossRefPubMed
4.
go back to reference Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12 (6): 421-9. 10.1016/S1044579X02000858.CrossRefPubMed Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12 (6): 421-9. 10.1016/S1044579X02000858.CrossRefPubMed
5.
go back to reference Busson P, Ooka T, Corbex M: Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. Med Sci (paris). 2004, 20 (4): 453-7.CrossRef Busson P, Ooka T, Corbex M: Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. Med Sci (paris). 2004, 20 (4): 453-7.CrossRef
6.
go back to reference Ou SH, Zell JA, Ziogas A, Anton-Culver H: Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007, 18 (1): 29-35. 10.1093/annonc/mdl320.CrossRefPubMed Ou SH, Zell JA, Ziogas A, Anton-Culver H: Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007, 18 (1): 29-35. 10.1093/annonc/mdl320.CrossRefPubMed
7.
go back to reference Ng WT, Choi CW, Lee MC, Chan SH, Yau TK, Lee AW: Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening. Fam Cancer. 2008 Ng WT, Choi CW, Lee MC, Chan SH, Yau TK, Lee AW: Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening. Fam Cancer. 2008
8.
go back to reference Akeshita H, Furukawa M, Fujieda S, Shoujaku H, Ookura T, Sakaguchi M, Ito H, Mineta H, Harada T, Matsuura H: Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan. Auris Nasus Larynx. 1999, 26 (3): 277-86. 10.1016/S0385-8146(98)00080-7.CrossRef Akeshita H, Furukawa M, Fujieda S, Shoujaku H, Ookura T, Sakaguchi M, Ito H, Mineta H, Harada T, Matsuura H: Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan. Auris Nasus Larynx. 1999, 26 (3): 277-86. 10.1016/S0385-8146(98)00080-7.CrossRef
9.
go back to reference Iraqi cancer Board: Annual Iraqi cancer registry bulletin. 2003 Iraqi cancer Board: Annual Iraqi cancer registry bulletin. 2003
10.
go back to reference Tang JG, Li Xuan, Cheng P: Expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection. J Zhejiang Univ SCI. 2004, 5 (10): 1304-1312. 10.1631/jzus.2004.1304.CrossRefPubMedPubMedCentral Tang JG, Li Xuan, Cheng P: Expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection. J Zhejiang Univ SCI. 2004, 5 (10): 1304-1312. 10.1631/jzus.2004.1304.CrossRefPubMedPubMedCentral
11.
go back to reference Serraino D, Piselli P, Angeletti C, Scuderi M, Ippolito G, Capobianchi MR: Infection with Epstein-Barr virus and cancer: an epidemiological review. J Biol Regul Homeost Agents. 2005, 19 (1–2): 63-70.PubMed Serraino D, Piselli P, Angeletti C, Scuderi M, Ippolito G, Capobianchi MR: Infection with Epstein-Barr virus and cancer: an epidemiological review. J Biol Regul Homeost Agents. 2005, 19 (1–2): 63-70.PubMed
12.
go back to reference Pattle SB, Farrell PJ: The role of Epstein-Barr virus in cancer. Expert Opin Biol Ther. 2006, 6 (11): 1193-205. 10.1517/14712598.6.11.1193.CrossRefPubMed Pattle SB, Farrell PJ: The role of Epstein-Barr virus in cancer. Expert Opin Biol Ther. 2006, 6 (11): 1193-205. 10.1517/14712598.6.11.1193.CrossRefPubMed
13.
go back to reference Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG: The Epstein-Barr virus and its association with human cancers. Mol Pathol. 1999, 52 (6): 307-322. 10.1136/mp.52.6.307.CrossRefPubMedPubMedCentral Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG: The Epstein-Barr virus and its association with human cancers. Mol Pathol. 1999, 52 (6): 307-322. 10.1136/mp.52.6.307.CrossRefPubMedPubMedCentral
14.
go back to reference UICC: TNM Classification of Malignant Tumors. 1978, 3 UICC: TNM Classification of Malignant Tumors. 1978, 3
15.
go back to reference Wakabayashi I, Kobaba-Wakabayashi R, Masuda H: Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. Diabetes Care. 2002, 25 (7): 1223-1228. 10.2337/diacare.25.7.1223.CrossRefPubMed Wakabayashi I, Kobaba-Wakabayashi R, Masuda H: Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. Diabetes Care. 2002, 25 (7): 1223-1228. 10.2337/diacare.25.7.1223.CrossRefPubMed
16.
go back to reference Schuurs A, Weeman V: Enzyme innunoassay. Clin Chem Acta. 1977, 31 (4): 1-40. 10.1016/0009-8981(77)90410-7.CrossRef Schuurs A, Weeman V: Enzyme innunoassay. Clin Chem Acta. 1977, 31 (4): 1-40. 10.1016/0009-8981(77)90410-7.CrossRef
17.
go back to reference Cheng WM, Chan KH, Chen HL, Luo RX, Ng SP, Luk W, Zheng BJ, Ji MF, Liang JS, Sham JS, et al: Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer. 2002, 97 (4): 489-492. 10.1002/ijc.1641.CrossRefPubMed Cheng WM, Chan KH, Chen HL, Luo RX, Ng SP, Luk W, Zheng BJ, Ji MF, Liang JS, Sham JS, et al: Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer. 2002, 97 (4): 489-492. 10.1002/ijc.1641.CrossRefPubMed
18.
go back to reference Koshiol J, Qiao YL, Mark SD, Dawsey SM, Abnet CC, Kamangar F, Lennette ET, Dong ZW, Taylor PR: Epstein-Barr virus serology and gastric cancer incidence and survival. Br J Cancer. 2007, 97 (11): 1567-1569. 10.1038/sj.bjc.6604063.CrossRefPubMedPubMedCentral Koshiol J, Qiao YL, Mark SD, Dawsey SM, Abnet CC, Kamangar F, Lennette ET, Dong ZW, Taylor PR: Epstein-Barr virus serology and gastric cancer incidence and survival. Br J Cancer. 2007, 97 (11): 1567-1569. 10.1038/sj.bjc.6604063.CrossRefPubMedPubMedCentral
19.
go back to reference Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, Ng MH, Middeldorp JM: Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Infect Dis. 2004, 190 (1): 53-62. 10.1086/421245.CrossRefPubMed Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, Ng MH, Middeldorp JM: Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Infect Dis. 2004, 190 (1): 53-62. 10.1086/421245.CrossRefPubMed
20.
go back to reference Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, et al: EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer. 2003, 105 (5): 706-709. 10.1002/ijc.11130.CrossRefPubMed Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, et al: EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer. 2003, 105 (5): 706-709. 10.1002/ijc.11130.CrossRefPubMed
21.
go back to reference Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S: Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998, 18 (6B): 4779-4786.PubMed Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S: Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998, 18 (6B): 4779-4786.PubMed
22.
go back to reference Young LS, Murray PG: Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003, 22 (33): 5108-5121. 10.1038/sj.onc.1206556.CrossRefPubMed Young LS, Murray PG: Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003, 22 (33): 5108-5121. 10.1038/sj.onc.1206556.CrossRefPubMed
23.
go back to reference Berrino F, Gatta G: Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer. 1998, 34 (14): 2154-2161. 10.1016/S0959-8049(98)00328-1.CrossRefPubMed Berrino F, Gatta G: Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer. 1998, 34 (14): 2154-2161. 10.1016/S0959-8049(98)00328-1.CrossRefPubMed
24.
go back to reference Terrell JE, Nanavati K, Esclamado RM, Bradford CR, Wolf GT: Health impact of head and neck cancer. Otolaryngol-Head-Neck-Surg. 1999, 120 (6): 852-9. 10.1016/S0194-5998(99)70326-8.CrossRefPubMed Terrell JE, Nanavati K, Esclamado RM, Bradford CR, Wolf GT: Health impact of head and neck cancer. Otolaryngol-Head-Neck-Surg. 1999, 120 (6): 852-9. 10.1016/S0194-5998(99)70326-8.CrossRefPubMed
25.
go back to reference Chang ET, Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15 (10): 1765-1777. 10.1158/1055-9965.EPI-06-0353.CrossRefPubMed Chang ET, Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15 (10): 1765-1777. 10.1158/1055-9965.EPI-06-0353.CrossRefPubMed
26.
go back to reference ong YS, Sham JS, Ng MH, Ou XT, Guo YQ, Zheng SA, Liang JS, Qiu H: Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 1992, 69 (1): 3-7. 10.1002/1097-0142(19920101)69:1<3::AID-CNCR2820690104>3.0.CO;2-7.CrossRef ong YS, Sham JS, Ng MH, Ou XT, Guo YQ, Zheng SA, Liang JS, Qiu H: Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 1992, 69 (1): 3-7. 10.1002/1097-0142(19920101)69:1<3::AID-CNCR2820690104>3.0.CO;2-7.CrossRef
27.
go back to reference Feinmesser R, Miyazaki I, Cheung R, Freeman JL, Noyek AM, Dosch HM: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med. 1992, 326 (1): 17-21.CrossRefPubMed Feinmesser R, Miyazaki I, Cheung R, Freeman JL, Noyek AM, Dosch HM: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med. 1992, 326 (1): 17-21.CrossRefPubMed
28.
go back to reference Zheng H, Li LL, Hu DS, Deng XY, Cao Y: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007, 4 (3): 185-196.PubMed Zheng H, Li LL, Hu DS, Deng XY, Cao Y: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007, 4 (3): 185-196.PubMed
Metadata
Title
The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types
Authors
AS Abdulamir
RR Hafidh
N Abdulmuhaimen
F Abubakar
KA Abbas
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2008
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-8-400

Other articles of this Issue 1/2008

BMC Public Health 1/2008 Go to the issue